Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126140741 | 12614074 | 1 | I | 20150507 | 20160721 | 20160802 | 20160802 | EXP | ES-AGEMED-742774440 | ES-PFIZER INC-2016357928 | PFIZER | 10.00 | YR | M | Y | 0.00000 | 20160802 | MD | ES | ES |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126140741 | 12614074 | 1 | PS | PAMIDRONATE DISODIUM. | PAMIDRONATE DISODIUM | 1 | Intravenous (not otherwise specified) | 60 MG, EVERY 3 MONTHS | 75841 | 60 | MG | SOLUTION FOR INJECTION | |||||||
126140741 | 12614074 | 2 | C | CALCIUM-SANDOZ D3 | 2 | Oral | 1 DF, 1X/DAY | 0 | 1 | DF | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126140741 | 12614074 | 1 | Osteogenesis imperfecta |
126140741 | 12614074 | 2 | Osteogenesis imperfecta |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126140741 | 12614074 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126140741 | 12614074 | Cellulitis | |
126140741 | 12614074 | Infusion site extravasation | |
126140741 | 12614074 | Pyrexia | |
126140741 | 12614074 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126140741 | 12614074 | 1 | 200801 | 0 | ||
126140741 | 12614074 | 2 | 200801 | 0 |